SHANG.FOS.PHARM.GR.H YC 1 (08HH) — Cash Flow Quality Index
SHANG.FOS.PHARM.GR.H YC 1 (08HH) has a Cash Flow Quality Index of 1.55x as of December 2025. Operating cash flow of €5.21 Billion exceeds net income of €3.37 Billion, indicating high earnings quality where cash backs reported profits. Also explore 08HH total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
SHANG.FOS.PHARM.GR.H YC 1 Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for SHANG.FOS.PHARM.GR.H YC 1 across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 08HH intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for SHANG.FOS.PHARM.GR.H YC 1 (2021–2025)
Year-by-year earnings quality comparison for SHANG.FOS.PHARM.GR.H YC 1. For live market cap and the full company financial profile, see SHANG.FOS.PHARM.GR.H YC 1 market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.55x | €5.21 Billion | €3.37 Billion | ▼ -4.3% |
| 2024 | 1.62x | €4.48 Billion | €2.77 Billion | ▲ +13.6% |
| 2023 | 1.42x | €3.41 Billion | €2.40 Billion | ▲ +26.1% |
| 2022 | 1.13x | €4.22 Billion | €3.74 Billion | ▲ +35.7% |
| 2021 | 0.83x | €3.94 Billion | €4.74 Billion | — |